<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200720048152N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-02-01</date_registration>
      <primary_sponsor>Kerman University of Medical Sciences</primary_sponsor>
      <public_title>The effect of Cupping on  lumbar pain of the elderly</public_title>
      <acronym>CT</acronym>
      <scientific_title>The effect of Cupping on nonspecific lumbar pain of the elderly referred to the Iranian Medicine Clinic.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-12-13</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/67767</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Other, Purpose: Treatment, Randomization description: Randomization is done in a simple way using a table of random numbers. The collaborator of the Project, who does not intervene in the research process, first prepares pockets according to sample size and numbers them, then based on the table of random numbers, randomly select a number and read the entire column bellow it vertically. The numbers whose right two digits are between 01 to 70 up to 35 numbers are placed in cupping therapy group and the rest 
are assigned to the placebo group. The type of treatment is written in each envelope and envelopes are closed and sealed. A four-digit code is written on each envelope. Two digits on the left correspond to the order of patient’s entry into the study and completes the informed consent form, are added to the first digits. an envelope is opened and the assigned group and day of visit is specified for that patient, Blinding description: In order to blind the study, The collaborator of the project, who was not involved in the treatment process or the data analysis process, puts the patients into two groups by a simple random method and using a sealed envelope. The first group is treated with dried cupping, and the second group is treated with placebo (cupping glasses are placed on the skin with a slight negative pressure and use of glue).</study_design>
      <phase>N/A</phase>
      <hc_freetext>low back pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: After random allocation of patients in to two groups of cupping therapy and placebo, in cupping therapy group, 4-10 acrylic cups with a diameter of 25-50 mm were used, the air inside them was heated by the flame of alcohol cotton and the cups were placed on paravertebral  region at a distance between l1 and l5 in parallel, for 7-10 minutes. As the air inside the cup cools down and creates suction, the skin is drawn into the cup due to the created vacuum. In such a way that the skin turns from bright red to dark pink. The duration of treatment is 10 days, into every other day in even or odds day to avoid patients of two groups confronting each other. Generally, each person is subjected to 5 sessions. If analgesics are needed, matching is done in both groups. Intervention 2: Control group: In the placebo group, by a manual cupping machine with a single suction and double adhesive support, 4-10 acrylic cups with a diameter of 25-50 mm, are attached only to the suction position on both sides of the vertebral column and in parallel at a distance between l1 and l5 (without changing the color of the skin). The cups are removed after 7-10 minutes. The duration of treatment is 10 days, into every other day in even or odds day to avoid patients of two groups confronting each other. Generally, each person is subjected to 5 sessions. If analgesics are needed, matching is done in both groups.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is privacy of patient information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ali Sarhadinejad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kerman University of Medical Sciences, Medical University Campus,     Haft-Bagh Highway, Kerman, Iran</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913555</zip>
        <telephone>+98 34 3132 5219</telephone>
        <email>A.sarhadi74@yahoo.com</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Esmat Nouhi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kerman University of Medical Sciences, Medical University Campus,     Haft-Bagh Highway, Kerman, Iran</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913555</zip>
        <telephone>091319888576</telephone>
        <email>smnouhi@yahoo.com</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Willingness and satisfaction of the patient to participate in the study
The presence of non-specific musculoskeletal pain in the lower back based on the doctors diagnosis
Age&gt;60 years (35)
Mild to moderate pain intensity 4-8  on VAS
Low back pain&gt;=3 month (8)
BMI &lt;35 (34)</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Back pain caused by trauma inflammatory or malignant disease
Presence of coagulopathy disease or anticoagulant agent consumption
Existence of radiculopathy symptoms such as radiating pain, paresis, prickling, or tingling of lower limb
Serious acute or chronic organic disease such as diabetes , mental disorders
Congenital malformation of the spine
Treatment with physiotherapy or opiates and other procedures within the last 4 weeks
Central Nervous System impairment</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>کمردرد</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: After random allocation of patients in to two groups of cupping therapy and placebo, in cupping therapy group, 4-10 acrylic cups with a diameter of 25-50 mm were used, the air inside them was heated by the flame of alcohol cotton and the cups were placed on paravertebral  region at a distance between l1 and l5 in parallel, for 7-10 minutes. As the air inside the cup cools down and creates suction, the skin is drawn into the cup due to the created vacuum. In such a way that the skin turns from bright red to dark pink. The duration of treatment is 10 days, into every other day in even or odds day to avoid patients of two groups confronting each other. Generally, each person is subjected to 5 sessions. If analgesics are needed, matching is done in both groups.</i_keyword>
      <i_keyword>Control group: In the placebo group, by a manual cupping machine with a single suction and double adhesive support, 4-10 acrylic cups with a diameter of 25-50 mm, are attached only to the suction position on both sides of the vertebral column and in parallel at a distance between l1 and l5 (without changing the color of the skin). The cups are removed after 7-10 minutes. The duration of treatment is 10 days, into every other day in even or odds day to avoid patients of two groups confronting each other. Generally, each person is subjected to 5 sessions. If analgesics are needed, matching is done in both groups.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Low back pain intensity. Timepoint: registration of daily  pain intensity from day 0-10. Method of measurement: Visual  Analog Scale questionnaire: VAS (0-10).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>with out grant</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-12-12</approval_date>
        <contact_name>Research Ethics Committees of Kerman University of Medical Sciences</contact_name>
        <contact_address>Kerman University of Medical Sciences, Medical University Campus,     Haft-Bagh Highway, Kerman, Iran Kerman Kerman Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
